|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.230 USD | +13.40% |
|
+14.02% | +25.52% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 4.94 | 4.94 | 5.23 |
| Spread/Res. | -14.37% | -14.37% | -19.12% |
| Spread/Supp. | +18.82% | +39.14% | +72.11% |
| Support | 3.56 | 3.04 | 2.458 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRWD Stock
- Charts Ironwood Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
